Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype
Theodore S. Hong(Massachusetts General Hospital), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Thomas F. DeLaney(Massachusetts General Hospital), Kenneth K. Tanabe(Harvard University), Ronald S. Arellano(Massachusetts General Hospital), Henning Willers(Massachusetts General Hospital), A. John Iafrate(Massachusetts General Hospital), Lipika Goyal(Stanford Medicine), Cristina R. Ferrone(Cedars-Sinai Medical Center), Janet E. Murphy(Harvard University), David P. Ryan(East Carolina University), Jennifer Y. Wo(Massachusetts General Hospital), Lawrence S. Blaszkowsky(Brigham and Women's Hospital), Harvey J. Mamon(Brigham and Women's Hospital), Jeffrey W. Clark(Massachusetts General Hospital), John T. Mullen(Massachusetts General Hospital), Eunice L. Kwak(Harvard University), Darrell R. Borger(Massachusetts Eye and Ear Infirmary), John A. Wolfgang(Massachusetts General Hospital), Jill N. Allen(Harvard University), Lorraine C. Drapek(Harvard University), Shyam Tanguturi(Harvard University), Beow Y. Yeap(Harvard University), Erin McDonnell(Harvard University)
Cited by 135
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k